Skip to main content
. 2023 May 4;33(5):566–577. doi: 10.1089/thy.2023.0035

Table 2.

Cases with Metastatic Lymph Nodes with BRAFVE Immunostain Performed on the Metastatic Lymph Nodes with Concomitant Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Feature

Cases (positive/total LN; pN stage) and positive BRAFVE on LN Size of largest metastatic focus, ENE Tumor size; histology; focality BRAFVE on PTC FNA category of PTC NIFTP size FNA category of NIFTP Molecular testing on NIFTP BRAFVE immunostain on NIFTP
Case 1 (2/16; pN1a) 0.2 cm, no ENE 4.2 cm; PTC; classic; multifocal Positive VI 0.5 Not performed
Case 2 (2/7; pN1a) 2.2 cm, no ENE 1.9 cm; PTC; infiltrative follicular; multifocal Positive VI 4.5 III Not performed
Case 3 (3/8; pN1b) 3.7 cm, no ENE 4.5 cm; PTC; tall cell; multifocal Positive V 1.3 Negative
Case 4 (5/15) 3.8 cm with ENE, 0.3 cm 1.4 cm; with diffuse sclerosing features; multifocal Positive VI 1.2 Negative
Case 5a (1/3) 0.8 cm, no ENE NA NA NA 5.5 II Not performed
Case 6a (4/5) 1.3 cm, with ENE, 0.1 cm NA NA NA 3.7 III Afirma suspicious Negative
a

Two cases presented with PTC metastatic to lymph nodes without primary thyroid PTC.

ENE, extranodal extension; LN, lymph nodes; NA, not applicable.